Intervention

rebimastat

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting0

Common conditions7

Lead sponsors shown2

Clinical trials

4 shown

BMS-275291 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone TherapyNCT00040755 · 2002-05-01

Zoledronate and BMS-275291 in Treating Patients With Prostate CancerNCT00039104 · 2002-04-01

BMS-275291 in Treating Patients With HIV-Related Kaposi's SarcomaNCT00024024 · 2001-08-01

Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung CancerNCT00006229 · 2000-04-04

Common conditions

Adenocarcinoma of the Prostate2 Recurrent Prostate Cancer2 Stage IV Prostate Cancer2 Bone Metastases1 Hormone-resistant Prostate Cancer1 Lung Cancer1 Sarcoma1

Leading sponsors

National Cancer Institute (NCI)3 NCIC Clinical Trials Group1

Trial status mix

COMPLETED4

Phase mix

PHASE24

PHASE11

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.